Before the study, each patient underwent a complete ophthalmic examination including visual acuity assessment, refraction, slit-lamp biomicroscopy, gonioscopy, Goldmann applanation tonometry, and dilated stereoscopic examination of the optic disc, as well as measurement of corneal curvature (KR-1800; Topcon, Tokyo, Japan), central corneal thickness (Orbscan II; Bausch & Lomb Surgical, Rochester, NY, USA), and axial length (IOL Master version 5; Carl Zeiss Meditec, Dublin, CA, USA), and stereo disc photography (EOS D60 digital camera; Canon, Utsunomiya-shi, Tochigi-ken, Japan), spectral-domain optical coherence tomography (SD-OCT, Spectralis OCT; Heidelberg Engineering, Heidelberg, Germany), and standard automated perimetry (Humphrey Field Analyzer II 750 and 24-2 Swedish interactive threshold algorithm; Carl Zeiss Meditec).
The inclusion criteria for the subjects were having POAG, a best-corrected visual acuity of at least 20/40, a spherical refraction of −8.0 to +3.0 diopters, and a cylinder correction within ±3.0 diopters. Primary open-angle glaucoma was defined as the presence of glaucomatous optic nerve damage (i.e., the presence of focal thinning, notching, or a splinter hemorrhage) and associated visual field defect without ocular diseases or conditions that may elevate the IOP. A glaucomatous visual field change was defined as (1) outside the normal limit on the glaucoma hemifield test, (2) three abnormal points with a P < 5% probability of being normal, one point with P < 1% by pattern deviation, or (3) a pattern standard deviation of P < 5% confirmed on two consecutive reliable tests. A visual field measurement was considered as reliable when both false-positive and false-negative results were <25% and fixation losses were <20%.
Those with a history of previous intraocular surgery or coexisting retinal (e.g., diabetic retinopathy, retinal vessel occlusion, or retinoschisis) or neurologic diseases (e.g., pituitary tumor) that could affect the visual field were excluded from this study. Secondary glaucoma (e.g., uveitic glaucoma) that may increase IOP was also excluded. Eyes were also excluded when a good-quality image (i.e., quality score > 15) could not be obtained in more than five sections, the quality score did not reach 15, the image-acquisition process automatically stopped, or images of the respective sections were not obtained. Eyes with tilted disc, and signs of hypotony, maculopathy, or disc edema after surgery were also excluded.
27
Indications for surgical treatment (trabeculectomy) were IOP deemed to be associated with a high risk of progression or glaucomatous progression of the visual field or optic disc, despite taking the maximum tolerated medications. All ocular hypotensive medications were continued up to the time of surgery. The preoperative IOP was defined as the average of two measurements made within 2 weeks before trabeculectomy.
Optic discs were examined by using SD-OCT at 1 day before surgery and 6 months postoperatively. Intraocular pressure measurements made by using Goldmann applanation tonometry were recorded at the follow-up visit.